Fundación Hemocentro Buenos Aires

What Fundación Hemocentro Buenos Aires does

Fundación Hemocentro Buenos Aires is a non-profit Regional Hemotherapy Center Level A, founded in 1998 (the foundation's legal incorporation is described as 2003 in some sources), located at Av. Díaz Vélez 3973 in Ciudad Autónoma de Buenos Aires, Argentina. It is the first regional hemotherapy center at the highest (Level A) certification level in the city, operating under the National Hemotherapy Services Registry of Argentina's Plan Nacional de Sangre. The foundation's core operations span voluntary blood donation (whole blood, plasma via plasmapheresis, platelets via plateletpheresis, and bone marrow donor registration through INCUCAI), processing of whole blood into hemocomponents (red blood cells, fresh plasma, platelets, cryoprecipitates) using closed-circuit multiple bag systems with barcode traceability, and serological and molecular biology testing. The foundation pioneered Nucleic Acid Testing (NAT) in Argentina beginning in 1994, using Roche's Cobas TaqScreen MPX Test to reduce detection windows for HIV, HCV, and HBV, and operates continuous flow cell separation equipment for apheresis procedures and platelet-rich plasma (PRP) preparation for therapeutic applications.

The foundation generates revenue through a combination of transaction-fee service agreements with 15+ affiliated sanatoriums and clinics (Clínica Bazterrica, Sanatorio Santa Isabel, Sanatorio Güemes, Sanatorio Otamendi y Miroli, Sanatorio Finochietto, Clínica del Sol, Medicus, Unidad Asistencial César Milstein, Hospital Garrahan, and others) for the daily provision of hemocomponents, a monthly plasma supply contract (~2,000 units) with the Universidad Nacional de Córdoba's Hemoderivatives Plant for production of albumin and gammaglobulin, professional services revenue from external blood collection campaigns (colectas) and educational courses (Seguridad Transfusional 4.0, AI in Transfusion Medicine), and donations via the DonarOnline platform. Pricing is not publicly disclosed. The foundation holds ISO 9001-2015 certification, ANMAT accreditation as a plasma provider for medicinal products, AAHI accreditation under MERCOSUR standards, and external quality control partnerships with CEMIC and Hospital Garrahan.

Go-to-market is community-led and direct-to-consumer: voluntary donor recruitment through the Club de Donantes Voluntarios, mobile blood drives at 100+ partner locations (schools, companies, clubs, religious institutions, and community organizations including Google, JP Morgan, River Plate, and UTHGRA), and creative digital campaigns including NFTs (VMLY&R Argentina), short films, and social media activations. The organization employs 11–50 staff and is governed by Director Médico Dr. Mariano Spotti and Gerente Administración Mario Alberto Spotti, with no external private equity or venture capital ownership. Operating geographies are domestic, limited to Argentina (Buenos Aires, Provincia de Buenos Aires, and Córdoba for plasma supply).

Name

Fundación Hemocentro Buenos Aires

Legal name

Fundación Hemocentro Buenos Aires

Website

https://www.hemocentro.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Fundación Hemocentro Buenos Aires is a non-profit first Level A regional hemotherapy center in Buenos Aires, Argentina, performing voluntary blood, plasma, and platelet collection, processing into hemocomponents, and distributing to 15+ clinics plus the Universidad Nacional de Córdoba hemoderivatives plant.

Ownership category

akta.pro rank

Product category

Blood Banking and Transfusion Services

NAICS

Blood and Organ Banks (621991), Voluntary Health Organizations (813212)

SIC

Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH), Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

Keywords

• Blood banking services
• Blood component processing
• Transfusion medicine services
• Voluntary blood donation
• Hemotherapy center services

Headquarters

HQ city

Concepción De Buenos Aires

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Hemocomponent Provision Agreements: The foundation provides blood components to affiliated sanatoriums, clinics, and healthcare institutions through formal agreements. Daily distribution of blood and hemocomponents to partnered clinics, with full cold chain maintenance during transport.
2. Plasma Supply to Hemoderivatives Plant: Supply of plasma to the Universidad Nacional de Córdoba Hemoderivatives Plant for production of albumin, gammaglobulin, and other blood-derived medications. Average delivery of 2,000 plasma units monthly.
3. Educational Courses and Training: Revenue from professional training courses including 'Seguridad Transfusional 4.0' and 'Inteligencia Artificial en Medicina Transfusional', offered through Aula de Medicina platform.
4. External Collection Services: Organization and execution of external blood donation campaigns (colectas) at partner companies, schools, and institutions, with funding from donors via DonarOnline platform.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Fundación Hemocentro Buenos Aires collects voluntary donations of whole blood, plasma, and platelets, screens donors via serological and molecular (NAT) testing, processes donations into hemocomponents (red blood cells, fresh plasma, platelets, cryoprecipitates), and distributes these to affiliated clinics, sanatoriums, and the Universidad Nacional de Córdoba Hemoderivatives Plant. It complements these core services with external blood drives, apheresis and platelet-rich plasma production, and professional education in transfusion medicine.

Product overview

Fundación Hemocentro Buenos Aires operates as a regional blood transfusion center providing a comprehensive portfolio of blood banking services. The core offering centers on voluntary blood donation (sangre), plasma donation (plasma), and platelet donation (plaquetas), complemented by bone marrow donor registration. The organization processes blood into hemocomponents (red blood cells, plasma, platelets, cryoprecipitates) using closed-circuit technology and distributes to partner clinics through formal agreements. Supporting services include serological testing for transmissible diseases (HIV, Hepatitis B/C, HTLV, Chagas, Brucellosis, Syphilis), molecular biology testing using Real-Time PCR for early disease detection, apheresis procedures for stem cell and platelet collection, and platelet-rich plasma (PRP) therapy. External blood drives extend reach into schools, companies, and community organizations, while education programs train professionals in transfusion medicine including AI applications. The voluntary donor club fosters regular donation habits to ensure stable blood supply.

Differentiator

Problem solved

Functional benefit

Brands

• Club de Donantes Voluntarios: Club for voluntary blood donors to encourage regular donation habits.
• Hemocentro

Products and services

• Blood Donation (Donación de Sangre) Voluntary blood donation services including donor screening, blood extraction, and processing into hemocomponents for transfusion to patients in need. Targeted at individual voluntary donors.
• Plasma Donation (Donación de Plasma) Plasma donation through plasmapheresis separating plasma from cellular components and returning red blood cells, white blood cells, and platelets to the donor. Can be performed every 20 days and supplies the Universidad Nacional de Córdoba Hemoderivatives Plant.
• Platelet Donation (Donación de Plaquetas) Platelet donation via plateletpheresis using apheresis technology, yielding 6-10 times more platelets than conventional blood donation, sufficient for a single patient transfusion from one donor.
• Bone Marrow Donor Registration (Donación de Médula Ósea) Registration service for potential bone marrow donors through the INCUCAI registry. Donors provide a blood sample to determine genetic compatibility codes for hematopoietic stem cell transplantation.
• External Blood Drives (Colectas Externas) Organized voluntary blood donation campaigns held at external locations including schools, companies, clubs, religious institutions, and community organizations, bringing donation opportunities closer to donors and institutional partners.
• Hemocomponents (Blood Component Processing) Processing of whole blood into components including red blood cells, fresh plasma, platelets, and cryoprecipitates using closed-circuit multiple bags, radio frequency tube sealers, and computerized barcode identification. Distributed to healthcare institutions under formal agreements.
• Serological Testing (Estudios Serológicos) Blood testing for transmissible diseases including HIV, Hepatitis B and C, HTLV I and II, Chagas, Brucellosis, and Syphilis as required by Argentine law, performed on every donation.
• Molecular Biology Testing (Biología Molecular) Nucleic Acid Testing (NAT) using Real-Time PCR (Cobas TaqScreen MPX Test by Roche) for early detection of Hepatitis B, Hepatitis C, and HIV, reducing detection window periods from 23/90/60 days to 5/5/35 days respectively.
• Apheresis (Aféresis) Continuous flow cell separation procedures including plateletpheresis for patients with high platelet consumption (e.g., leukemia patients), stem cell collection for transplants, and plasma collection for hemoderivative manufacturing.
• Platelet-Rich Plasma (PRP) Therapy Autologous platelet-rich plasma therapy for tissue regeneration, releasing growth factors (EGF, PDGF, VEGF, FGF, TGF-beta, IGF) used in dentistry, orthopedic surgery, diabetic ulcer treatment, and aesthetic medicine.
• Seguridad Transfusional 4.0 (Transfusion Safety 4.0 Course) Virtual asynchronous professional training course covering serological and molecular screening, transmissible infection markers, biological foundations, diagnostic criteria, risk analysis, quality control, and interpretation of transfusion medicine results. Targeted at healthcare professionals.
• Inteligencia Artificial en Medicina Transfusional (AI in Transfusion Medicine Course) Intensive 5-session professional course designed to integrate AI tools (ChatGPT, Gemini, NotebookLM) into transfusion medicine practice, covering documentation automation, donor message personalization, predictive demand modeling, and AI-driven medical interview simulation. Targeted at physicians, biologists, biochemists, donation promoters, and technical staff.
• IV Jornadas Internacionales de Medicina Transfusional (IV International Transfusion Medicine Conference) International professional conference series covering storage lesion mitigation, cold chain best practices, white blood cells in transfusion medicine, cryopreserved platelets, microbiological control in platelets, platelet refractoriness management, universal leukoreduction economic impact, and blood bank cybersecurity. Co-organized with Laboratorio Macopharma.

Quantifiable outcome

• HIV window period reduced from 23 days to 5 days using NAT testing
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Laboratorio MacopharmacoreStrategic or Co-development Partner · 1 January 2026Co-organizer of IV International Transfusion Medicine Congress (Jornadas Internacionales de Medicina Transfusional 2026), held on June 4, July 2, August 13, and September 10, 2026.
• Club Atlético River PlateminorGTM or Marketing Partner · 1 January 2025Host venue for external blood collection campaigns in 2025.
• Google ArgentinaminorGTM or Marketing Partner · 1 January 2025Corporate partner hosting blood donation campaigns at their Buenos Aires office.
• JP MorganminorGTM or Marketing Partner · 1 January 2025Corporate partner hosting blood donation campaigns for employees.
• UTHGRA (Unión de Trabajadores del Turismo, Hoteles y Gastronómicos)minorGTM or Marketing Partner · 1 January 2025Union with multiple branches (Central, Lomas de Zamora, Quilmes, San Isidro, San Justo, San Martín) hosting blood donation campaigns.
• Clínica BazterricacoreOthersHealthcare provider receiving hemocomponents and blood products for patient care and transfusions.
• Sanatorio Santa IsabelcoreOthersHealthcare institution receiving blood components and hemocomponents for transfusion services.
• Sanatorio GüemescoreOthersHealthcare institution receiving blood components for patient care.
• Sanatorio Otamendi y MirolicoreOthersHealthcare institution receiving blood components for transfusion services.
• Clínica del SolcoreOthersHealthcare institution receiving hemocomponents for patient care.
• MedicuscoreOthersHealthcare provider receiving blood components for medical services.
• Sanatorio FinochiettocoreOthersHealthcare institution receiving blood components for patient care and surgeries.
• Hospital de Pediatría SAMIC Prof. Dr. Juan P. GarrahancoreOthersExternal quality control partner for blood component testing validation. Major pediatric hospital in Argentina.
• Universidad Nacional de Córdoba - HemoderivadoscoreOthersReceives plasma supply (approximately 2,000 units monthly) for production of albumin, gammaglobulin, and other blood derivatives. Accredited laboratory.
• Centro de Educación Médica e Investigaciones Clínicas (CEMIC)minorOthersExternal quality control partner for blood component testing.
• Roche LaboratoriescoreTechnology or IntegrationProvider of Cobas TaqScreen MPX Test for Real-Time PCR nucleic acid amplification testing (NAT) for early detection of HIV, HCV, and HBV in blood donations.
• Aula de MedicinacoreChannel Partner/ Reseller/ DistributorEducational platform for distribution of professional training courses including Seguridad Transfusional 4.0 and Inteligencia Artificial en Medicina Transfusional.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• New York Blood Center: Large US nonprofit blood center collecting, processing, and distributing blood components to hospitals. Directly comparable as a non-profit regional hemotherapy operator with regulatory accreditations and B2B hospital supply agreements.
• Vitalant: One of the largest nonprofit blood and biotherapy organizations in the US, operating blood collection, component processing, and hospital distribution. Closely comparable in mission, nonprofit structure, and service portfolio.
• Canadian Blood Services: National nonprofit blood operator managing donor recruitment, collection, testing (including NAT), and hospital distribution across Canada. Comparable as a regulated, nonprofit hemotherapy provider at scale.
• NHS Blood and Transplant: UK public-sector blood and transplant service operating donor centers, component processing, NAT screening, and hospital supply. Comparable in component processing, screening technology, and B2B hospital distribution.
• Sanquin Blood Bank: Dutch nonprofit blood bank collecting and processing blood components, supplying plasma-derived products internationally, and operating educational programs. Comparable as a vertically integrated nonprofit hemotherapy organization.
• Australian Red Cross Lifeblood: Australian nonprofit blood operator managing voluntary donor recruitment, processing, and hospital supply. Comparable in mission, community-driven GTM, and regulated component distribution.

Broad incumbents

• American Red Cross Biomedical Services: Largest US blood collection organization with national reach across whole blood, platelets, and plasma. Comparable in nonprofit voluntary donor model but operates at far greater scale and geographic breadth than Hemocentro.

Regional players

• Hospital Italiano de Buenos Aires — Blood Bank: In-hospital blood bank in Buenos Aires performing donor collection, screening (including NAT), and component preparation for internal and affiliated use. Comparable as a Buenos Aires-based nonprofit-adjacent hemotherapy operator, though embedded in a larger hospital system.
• Cruz Roja Argentina: Argentine Red Cross chapter historically involved in voluntary blood donor campaigns. Comparable as a community-driven, nonprofit blood donor organization operating in the same Argentine market and donor recruitment channels.

Others

• Universidad Nacional de Córdoba — Laboratorio de Hemoderivados: Argentine public plasma fractionator that produces albumin, immunoglobulins, and other blood-derived medications. Comparable as the downstream industrial buyer of Hemocentro's plasma; relevant as ecosystem partner rather than competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/hemocentrobsas
• Facebookfacebook.com/Hemocentro
• Instagraminstagram.com/hemocentro
• LinkedInlinkedin.com/company/hemocentro

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundación Hemocentro Buenos Aires